Article

March 28, 2011

HIT Press Club AJMC - Dr. Deneen Vojta

Author(s):

Deneen Vojta, MD

Dr. Deneen Vojta, UnitedHealthcare, discusses her paper and answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club.

Dr. Deneen Vojta, Senior Vice President of Innovations at UnitedHealthcare, discusses her paper, "Health Information Technology and Health System Redesign: The Quality Chasm Revisited." She also answers questions at the Healthcare Innovations and HIT Q&A Session at the National Press Club in Washington, DC.

Related Videos

Jonathan Eisengart

Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center

Jonathan Eisengart

Tiago Biachi, MD, PhD

Irina Dralyuk

Edgardo S. Santos, MD, FACP, FASCO

Irina Dralyuk

Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine

Robin Glasco, Spencer Stuart

Related Content

AI illustration | Image Credit: putilov_denis - stock.adobe.com

January 19th 2025

AI Outperforms Traditional Methods in Predicting Ovarian Cancer Surgery Outcomes

Brooke McCormick

Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional methods in predicting post–complete cytoreduction outcomes in patients with ovarian cancer, including overall survival, no residual disease, and postoperative complications.

Managed Care Cast

January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Karen Winkfield, MD, PhD, Vanderbilt University Medical Center

January 15th 2025

Building Trust Through Community Engagement in Cancer Care

In part 2 of our interview with Karen Winkfield, MD, PhD, she speaks to the importance of ensuring health care accessibility and of knowing that the health care system is not a one-size-fits-all arrangement.

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.

January 13th 2025

Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy

Cameron Santoro

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially benefit from shorter or less-intensive treatment.

Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

Related Content

AI illustration | Image Credit: putilov_denis - stock.adobe.com

January 19th 2025

AI Outperforms Traditional Methods in Predicting Ovarian Cancer Surgery Outcomes

Brooke McCormick

Artificial intelligence (AI) models, particularly artificial neural networks and machine learning, outperform traditional methods in predicting post–complete cytoreduction outcomes in patients with ovarian cancer, including overall survival, no residual disease, and postoperative complications.

Managed Care Cast

January 14th 2025

Frameworks for Advancing Health Equity: Accessing Ketamine-Assisted Therapy

Giuliana Grossi

Jessica Tracy, head of Growth and Partnerships at Enthea, shares how employers and unions can support mental health and address access barriers to evidence-based ketamine treatments.

Karen Winkfield, MD, PhD, Vanderbilt University Medical Center

January 15th 2025

Building Trust Through Community Engagement in Cancer Care

In part 2 of our interview with Karen Winkfield, MD, PhD, she speaks to the importance of ensuring health care accessibility and of knowing that the health care system is not a one-size-fits-all arrangement.

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

December 26th 2024

Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

Marie-France Jilderda, MD, PhD Candidate Surgical Oncology at Leiden University Medical Center in the Netherlands.

January 13th 2025

Identifying Patients With Low-Risk Breast Cancer for De-escalated Therapy

Cameron Santoro

A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially benefit from shorter or less-intensive treatment.

Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine

January 12th 2025

Designing Care for the Underserved Creates Higher-Value Health Solutions

In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions